NCT02242630View on ClinicalTrials.gov

Relationship to Dose of Triamcinolone Acetonide and Methylyprednisolone to Improvement in Subacromial Bursitis

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

Subacromial BursitisShoulder Pain

Interventions

DRUG

Methylprednisolone, 20 mg

Compared with intrabursal triamcinolone

DRUG

Methylprednisolone, 40 mg

Compared with intrabursal triamcinolone

DRUG

Triamcinolone, 20 mg

Compared with methylprednisolone

DRUG

Triamcinolone, 40 mg

Compared with methylprednisolone

Trial Locations (1)

39534

Keesler Medical Center, Keesler Air Force Base

All Listed Sponsors

lead

Keesler Air Force Base Medical Center

FED

NCT02242630 - Relationship to Dose of Triamcinolone Acetonide and Methylyprednisolone to Improvement in Subacromial Bursitis | Biotech Hunter | Biotech Hunter